Human Tumor Sequencing Project

Completed

• Conditions: Cancer

• Registration Number: NCT01608230
• Lead Sponsor: Scripps Translational Science Institute

Brief Summary

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2012-05-25
• Study First Submitted QC: 2012-05-25
• Study First Posted: 2012-05-31
• Primary Completion: 2014-04
• Study Completion: 2014-04
• Status Verified: 2014-11
• Last Update Submitted: 2014-11-17
• Last Update Posted: 2014-11-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• Diagnosis of a solid tumor or blood borne cancer
• 18 years or older
• Eligible to have blood drawn

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determine biomarkers of clinical utility and copy number variants through genetic analysis.	four years

Trial Locations

Locations (1)

Scripps Translational Science Institute; 🇺🇸 La Jolla, California, United States